recombinant FVIIa

Known as: recombinant FVIIa [Chemical/Ingredient], recombinant coagulation factor viia, FACTOR VIIa,RECOMBINANT 
 

Topic mentions per year

Topic mentions per year

1989-2017
05010019892017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND The use of recombinant activated factor VII (rFVIIa) on an off-label basis to treat life-threatening bleeding has been… (More)
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The development of inhibitory antibodies to factor VIII is a serious complication of hemophilia. FEIBA (factor VIII inhibitor… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Hemophilic patients with factor VIII (FVIII) and FIX inhibitors suffer from frequent bleeding episodes and reduced… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND AND PURPOSE We report an exploratory analysis from a randomized study of recombinant activated factor VII (rFVIIa) in… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Although volume of intracerebral hemorrhage (ICH) is a predictor of mortality, it is unknown whether subsequent… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE To evaluate predictors of intraventricular hemorrhage (IVH) and IVH growth, impact of IVH growth on outcome, and impact… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Uncontrolled bleeding is a leading cause of death in trauma. Two randomized, placebo-controlled, double-blind trials… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2003
2003
BACKGROUND Recombinant FVIIa (rFVIIa/NovoSeven) is a novel hemostatic agent originally developed to treat patients with… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Bleeding associated with warfarin anticoagulation correlates directly to duration and degree of international… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Recombinant activated factor VII (rFVIIa) was approved for treatment of hemorrhages in patients with hemophilia who… (More)
Is this relevant?